125 related articles for article (PubMed ID: 30542533)
21. New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes.
Sahebkar A; Watts GF
Clin Ther; 2013 Aug; 35(8):1082-98. PubMed ID: 23932550
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of cholesterol esterification by DuP 128 decreases hepatic apolipoprotein B secretion in vivo: effect of dietary fat and cholesterol.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Huff MW
Biochim Biophys Acta; 1998 Jul; 1393(1):63-79. PubMed ID: 9714740
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of hepatic ACAT decreases ApoB secretion in miniature pigs fed a cholesterol-free diet.
Huff MW; Telford DE; Barrett PH; Billheimer JT; Gillies PJ
Arterioscler Thromb; 1994 Sep; 14(9):1498-508. PubMed ID: 8068612
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2589-600. PubMed ID: 9409231
[TBL] [Abstract][Full Text] [Related]
25. Tribbles homolog 1 enhances cholesterol efflux from oxidized low-density lipoprotein-loaded THP-1 macrophages.
Fu Y; Zhao Y; Huang B
Exp Ther Med; 2017 Jul; 14(1):862-866. PubMed ID: 28673011
[TBL] [Abstract][Full Text] [Related]
26. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
[TBL] [Abstract][Full Text] [Related]
27. Metabolism of apolipoprotein B-100 and of triglyceride-rich lipoprotein particles in the absence of functional lipoprotein lipase.
Pacy PJ; Mitropoulos KA; Venkatesan S; Watts GF; Reeves BE; Halliday D
Atherosclerosis; 1993 Nov; 103(2):231-43. PubMed ID: 8292098
[TBL] [Abstract][Full Text] [Related]
28. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
[TBL] [Abstract][Full Text] [Related]
29. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.
Jong MC; Dahlmans VE; van Gorp PJ; van Dijk KW; Breuer ML; Hofker MH; Havekes LM
J Clin Invest; 1996 Nov; 98(10):2259-67. PubMed ID: 8941642
[TBL] [Abstract][Full Text] [Related]
30. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.
Watts GF; Barrett PH; Ji J; Serone AP; Chan DC; Croft KD; Loehrer F; Johnson AG
Diabetes; 2003 Mar; 52(3):803-11. PubMed ID: 12606523
[TBL] [Abstract][Full Text] [Related]
31. Regulation of triglyceride synthesis by estradiol in the livers of hybrid tilapia (Oreochromis niloticus ♀ × O. aureus ♂).
Zhang X; Han Z; Zhong H; Yin Q; Xiao J; Wang F; Zhou Y; Luo Y
Comp Biochem Physiol B Biochem Mol Biol; 2019 Dec; 238():110335. PubMed ID: 31473330
[TBL] [Abstract][Full Text] [Related]
32. Complex effects of inhibiting hepatic apolipoprotein B100 synthesis in humans.
Reyes-Soffer G; Moon B; Hernandez-Ono A; Dionizovik-Dimanovski M; Jimenez J; Obunike J; Thomas T; Ngai C; Fontanez N; Donovan DS; Karmally W; Holleran S; Ramakrishnan R; Mittleman RS; Ginsberg HN
Sci Transl Med; 2016 Jan; 8(323):323ra12. PubMed ID: 26819195
[TBL] [Abstract][Full Text] [Related]
33. HOE 402 lowers serum cholesterol levels by reducing VLDL-lipid production, and not by induction of the LDL receptor, and reduces atherosclerosis in wild-type and LDL receptor-deficient mice.
Draijer R; Volger OL; Dahlmans VE; de Wit EC; Havekes LM; Princen HM
Biochem Pharmacol; 2002 May; 63(9):1755-61. PubMed ID: 12007578
[TBL] [Abstract][Full Text] [Related]
34. Keep recycling going: New approaches to reduce LDL-C.
Klein-Szanto AJP; Bassi DE
Biochem Pharmacol; 2019 Jun; 164():336-341. PubMed ID: 30953636
[TBL] [Abstract][Full Text] [Related]
35. Effect of reduced low-density lipoprotein receptor level on HepG2 cell cholesterol metabolism.
Izem L; Rassart E; Kamate L; Falstrault L; Rhainds D; Brissette L
Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):81-9. PubMed ID: 9405278
[TBL] [Abstract][Full Text] [Related]
36. miR-130b is a potent stimulator of hepatic very-low-density lipoprotein assembly and secretion via marked induction of microsomal triglyceride transfer protein.
Zhang J; Jazii FR; Haghighi MM; Alvares D; Liu L; Khosraviani N; Adeli K
Am J Physiol Endocrinol Metab; 2020 Feb; 318(2):E262-E275. PubMed ID: 31821038
[TBL] [Abstract][Full Text] [Related]
37. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
[TBL] [Abstract][Full Text] [Related]
38. Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity.
Riches FM; Watts GF; Naoumova RP; Kelly JM; Croft KD; Thompson GR
Int J Obes Relat Metab Disord; 1998 May; 22(5):414-23. PubMed ID: 9622338
[TBL] [Abstract][Full Text] [Related]
39. LDL size distribution in relation to insulin sensitivity and lipoprotein pattern in young and healthy subjects.
Ambrosch A; Mühlen I; Kopf D; Augustin W; Dierkes J; König W; Luley C; Lehnert H
Diabetes Care; 1998 Dec; 21(12):2077-84. PubMed ID: 9839097
[TBL] [Abstract][Full Text] [Related]
40. No effect of menstrual cycle phase on basal very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics.
Magkos F; Patterson BW; Mittendorfer B
Am J Physiol Endocrinol Metab; 2006 Dec; 291(6):E1243-9. PubMed ID: 16835398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
